NO160103C - Jodtyroninimmunogenkonjugat og jodtyroninderivat for fremstilling av jodtyroninimmunogenkonjugatet. - Google Patents

Jodtyroninimmunogenkonjugat og jodtyroninderivat for fremstilling av jodtyroninimmunogenkonjugatet.

Info

Publication number
NO160103C
NO160103C NO823657A NO823657A NO160103C NO 160103 C NO160103 C NO 160103C NO 823657 A NO823657 A NO 823657A NO 823657 A NO823657 A NO 823657A NO 160103 C NO160103 C NO 160103C
Authority
NO
Norway
Prior art keywords
nimmunogen
iodtyronin
conjugate
iodtyron
ingredients
Prior art date
Application number
NO823657A
Other languages
English (en)
Norwegian (no)
Other versions
NO160103B (no
NO823657L (no
Inventor
James Paul Albarella
Robert Joseph Carrico
Thomas M Li
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/318,026 external-priority patent/US4358604A/en
Application filed by Miles Inc filed Critical Miles Inc
Publication of NO823657L publication Critical patent/NO823657L/no
Publication of NO160103B publication Critical patent/NO160103B/no
Publication of NO160103C publication Critical patent/NO160103C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO823657A 1981-11-04 1982-11-03 Jodtyroninimmunogenkonjugat og jodtyroninderivat for fremstilling av jodtyroninimmunogenkonjugatet. NO160103C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/318,026 US4358604A (en) 1981-11-04 1981-11-04 N-Aminoalkyl iodothyronine derivatives
US06/363,084 US4399121A (en) 1981-11-04 1982-03-29 Iodothyronine immunogens and antibodies

Publications (3)

Publication Number Publication Date
NO823657L NO823657L (no) 1983-05-05
NO160103B NO160103B (no) 1988-11-28
NO160103C true NO160103C (no) 1989-03-08

Family

ID=26981272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823657A NO160103C (no) 1981-11-04 1982-11-03 Jodtyroninimmunogenkonjugat og jodtyroninderivat for fremstilling av jodtyroninimmunogenkonjugatet.

Country Status (11)

Country Link
US (1) US4399121A (de)
EP (1) EP0078952B1 (de)
AU (1) AU532580B2 (de)
CA (1) CA1210758A (de)
DE (1) DE3269443D1 (de)
DK (1) DK488882A (de)
ES (1) ES8500453A1 (de)
GR (1) GR76787B (de)
IE (1) IE54236B1 (de)
IL (1) IL66781A0 (de)
NO (1) NO160103C (de)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210420A (en) * 1983-12-06 1988-04-29 Merrell Dow Pharma D-amino acid oxidase substrates and pharmaceutical compositions
US4595656A (en) * 1984-01-06 1986-06-17 Becton Dickinson & Company Coupling agents and products produced therefrom
US4670406A (en) * 1984-01-06 1987-06-02 Becton Dickinson And Company Tracers for use in assays
US4530786A (en) * 1984-09-04 1985-07-23 Colorado State University Research Foundation Antibody for the detection and quantification of atrazine
DE3628795A1 (de) * 1986-08-25 1988-03-03 Hoechst Ag Neue thyroninderivate
DE68928124T2 (de) 1988-09-02 1997-10-16 Chiron Corp., Emeryville, Calif. Makrophagenabgeleiteter entzündungsmediator(mip-2)
US5767227A (en) * 1989-11-03 1998-06-16 Lotus Biochemical Corp. Iodothyronine polymers
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US6190864B1 (en) 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
US5527709A (en) * 1992-06-26 1996-06-18 Johnson & Johnson Clinical Diagnostics, Inc. Immunoassays with labeled thyronine hapten analogues
US5273885A (en) * 1992-07-31 1993-12-28 Syntex (U.S.A.) Inc. Conjugates of monophenyl thyroid analogs useful in assays
CA2162557C (en) 1993-05-12 2004-09-28 Amy J. Weiner Conserved motif of hepatitis c virus e2/ns1 region
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6124448A (en) * 1994-08-17 2000-09-26 The Rockfeller University Nucleic acid primers and probes for the mammalian OB gene
US6124439A (en) * 1994-08-17 2000-09-26 The Rockefeller University OB polypeptide antibodies and method of making
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6528271B1 (en) * 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
US7541151B2 (en) 1997-06-05 2009-06-02 Duke University Single-cell biosensor for the measurement of GPCR ligands in a test sample
US5891646A (en) * 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
EP1037909B1 (de) 1997-12-11 2007-06-13 University of Saskatchewan Multisystemisches kümmerwuchssyndrom durch viren in schweine
EP1816200B1 (de) 1997-12-11 2016-03-09 Merial Virus des multisystemischen Kümmersyndroms bei Absatzferkeln
US6087128A (en) 1998-02-12 2000-07-11 Ndsu Research Foundation DNA encoding an avian E. coli iss
US6369201B1 (en) 1998-02-19 2002-04-09 Metamorphix International, Inc. Myostatin multimers
US6773911B1 (en) * 1998-11-23 2004-08-10 Amgen Canada Inc. Apoptosis-inducing factor
AU4673099A (en) 1999-02-26 2000-09-14 Chiron Corporation Use of bioadhesives and adjuvants for the mucosal delivery of antigens
US7018654B2 (en) * 1999-03-05 2006-03-28 New River Pharmaceuticals Inc. Pharmaceutical composition containing an active agent in an amino acid copolymer structure
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6399759B1 (en) 1999-05-27 2002-06-04 University Of Georgia Research Foundation, Inc. Ant proteases and methods of inhibition
NZ518601A (en) 1999-09-24 2004-10-29 Morphogen Pharmaceuticals Inc Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US6627660B1 (en) 1999-11-16 2003-09-30 New River Pharmaceuticals Inc. Stabilized thyroxine compounds
DE19957065B4 (de) 1999-11-26 2005-01-05 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Screening-Verfahren für Arzneistoffe
CA2395443A1 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
US20020064861A1 (en) * 2000-01-11 2002-05-30 Barletta Raul G. Identification of virulence determinants
AU2001227385A1 (en) 2000-01-21 2001-07-31 Hyseq, Inc. Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
CA2901451C (en) 2000-05-10 2020-04-07 Moses Rodriguez Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
EP1734050A3 (de) 2000-06-12 2012-12-05 University Of Saskatchewan Immunisation von Milchvieh mit GapC Protein gegen Streptococcusinfektion
US20020099013A1 (en) * 2000-11-14 2002-07-25 Thomas Piccariello Active agent delivery systems and methods for protecting and administering active agents
US7163918B2 (en) 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US7018812B2 (en) 2000-11-03 2006-03-28 Duke University Modified G-protein coupled receptors
US7163800B2 (en) * 2000-11-03 2007-01-16 Molecular Devices Corporation Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US20050136431A1 (en) * 2000-11-03 2005-06-23 Oakley Robert H. Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US8394813B2 (en) * 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
AU2002241189A1 (en) * 2000-12-23 2002-07-08 Kirin Beer Kabushiki Kaisha Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
US6673904B2 (en) 2000-12-23 2004-01-06 Kirin Beer Kabushiki Kaisha Stem cell growth factor-like polypeptides
CA2447139C (en) 2001-05-11 2013-11-19 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
US20110313230A1 (en) 2001-05-11 2011-12-22 Terrance Grant Johns Specific binding proteins and uses thereof
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
US20090324612A1 (en) * 2001-06-05 2009-12-31 Kaufman Daniel L Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
WO2002099069A2 (en) * 2001-06-05 2002-12-12 The Regents Of The University Of California Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US20070066537A1 (en) * 2002-02-22 2007-03-22 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7375082B2 (en) * 2002-02-22 2008-05-20 Shire Llc Abuse-resistant hydrocodone compounds
US7338939B2 (en) * 2003-09-30 2008-03-04 New River Pharmaceuticals Inc. Abuse-resistant hydrocodone compounds
EP1978108A3 (de) 2002-01-08 2009-01-07 Siemens Healthcare Diagnostics GmbH Einzelnukleotidpolymorphismen zur Vorhersage kardiovaskulärer Erkrankungen und Medikationswirkung
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
CA2477004C (en) * 2002-02-22 2011-05-10 Thomas Piccariello Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US20030182669A1 (en) * 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
US7290215B2 (en) * 2002-06-03 2007-10-30 Microsoft Corporation Dynamic wizard interface system and method
EP2371955A1 (de) 2002-09-26 2011-10-05 K.U. Leuven Research & Development Integrase-Cofaktor
AU2002953431A0 (en) * 2002-12-19 2003-01-09 Murdoch University BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof
CA2514179A1 (en) * 2003-01-24 2004-08-12 Duke University Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera
AU2004251647B2 (en) * 2003-05-29 2010-01-14 Takeda Pharmaceutical Company Limited Abuse resistant amphetamine compounds
US20060035242A1 (en) 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
BRPI0414876A (pt) * 2003-09-30 2006-11-21 New River Pharmaceuticals Inc compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
US7767792B2 (en) 2004-02-20 2010-08-03 Ludwig Institute For Cancer Research Ltd. Antibodies to EGF receptor epitope peptides
WO2006119983A2 (en) 2005-05-12 2006-11-16 Novartis Ag Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
US7780969B2 (en) * 2005-07-15 2010-08-24 University Of Georgia Research Foundation, Inc. Trypanosoma cruzi proteome compositions and methods
EP2019687B1 (de) 2006-03-29 2014-03-19 Merial Limited Impfstoff gegen streptokokken
EP3147365B1 (de) 2006-04-21 2019-12-04 Intervet International B.V. Pestivirusspezies
CN101821284B (zh) 2007-08-03 2014-11-19 贝林格尔·英格海姆维特梅迪卡有限公司 猪痢疾短螺旋体的基因和蛋白质及其用途
EP2363407A1 (de) 2008-02-28 2011-09-07 Murdoch University Neuartige Brachyspira-Sequenzen, immunogene Zusammensetzungen, Herstellungsverfahren dafür und Verwendung davon
EP2530087B1 (de) 2008-03-27 2018-05-02 Murdoch University Brachyspira-Sequenzen, immunogene Zusammensetzungen, Herstellungsverfahren dafür und Verwendung davon
CA2758542A1 (en) 2009-04-17 2010-10-21 New York University Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
US20110076232A1 (en) 2009-09-29 2011-03-31 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
WO2011084882A2 (en) 2010-01-05 2011-07-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
WO2011113118A1 (en) 2010-03-19 2011-09-22 Katholieke Universiteit Leuven Drug tolerance/persistence of fungal biofilms
EP2576622A4 (de) 2010-06-01 2013-11-27 Univ Monash Auf die unverarbeitete rezeptor-tyrosin-kinase c-met zielende antikörper
SG190793A1 (en) 2010-11-11 2013-07-31 Agency Science Tech & Res Targeting metabolic enzymes in human cancer
GB201107467D0 (en) 2011-05-05 2011-06-15 Univ Leuven Kath Novel treatment of pain
PL2872157T3 (pl) 2012-07-12 2020-07-13 Hangzhou Dac Biotech Co., Ltd Koniugaty wiążących komórkę cząsteczek ze środkami cytotoksycznymi
WO2014080251A1 (en) 2012-11-24 2014-05-30 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
EP3013857B1 (de) 2013-06-28 2021-06-23 Singapore Health Services Pte Ltd Trpm4-kanalinhibitoren für die behandlung von schlaganfall
CN107074879B (zh) 2013-09-02 2022-04-15 杭州多禧生物科技有限公司 应用于细胞结合分子-药物共轭体的新型细胞毒性分子
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN110099682B (zh) 2016-11-14 2023-03-31 杭州多禧生物科技有限公司 偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
US20230025327A1 (en) 2019-06-29 2023-01-26 Hangzhou Dac Biotech Co., Ltd. Conjugates of tubulysin derivatives and cell binding molecules and methods of making
CN115397848A (zh) 2020-02-05 2022-11-25 拉利玛生物医药公司 Tat肽结合蛋白及其用途
EP3862023A1 (de) 2020-02-05 2021-08-11 Hangzhou DAC Biotech Co, Ltd Konjugate aus zellbindenden molekülen mit zytotoxika

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2818644C2 (de) * 1978-04-27 1983-09-29 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Mit radioaktivem Jod markierte 3'-Brom-thyrocarbonsäurederivate und Verfahren zu deren Herstellung
US4171432A (en) * 1978-06-22 1979-10-16 Miles Laboratories, Inc. Flavin adenine dinucleotide-iodothyronine conjugates
US4259232A (en) * 1979-10-23 1981-03-31 Miles Laboratories, Inc. Flavin adenine dinucleotide-labeled protein and polypeptide conjugates
US4259233A (en) * 1979-10-23 1981-03-31 Miles Laboratories, Inc. β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates
US4358604A (en) * 1981-11-04 1982-11-09 Miles Laboratories, Inc. N-Aminoalkyl iodothyronine derivatives

Also Published As

Publication number Publication date
GR76787B (de) 1984-09-04
DE3269443D1 (en) 1986-04-03
ES517080A0 (es) 1984-10-01
EP0078952A1 (de) 1983-05-18
US4399121A (en) 1983-08-16
IE54236B1 (en) 1989-08-02
ES8500453A1 (es) 1984-10-01
IL66781A0 (en) 1982-12-31
IE822629L (en) 1983-05-04
AU8727782A (en) 1983-07-07
NO160103B (no) 1988-11-28
EP0078952B1 (de) 1986-02-26
NO823657L (no) 1983-05-05
DK488882A (da) 1983-05-05
AU532580B2 (en) 1983-10-06
CA1210758A (en) 1986-09-02

Similar Documents

Publication Publication Date Title
NO160103C (no) Jodtyroninimmunogenkonjugat og jodtyroninderivat for fremstilling av jodtyroninimmunogenkonjugatet.
MX9203151A (es) Conjugado inmunogenico.
NO158002C (no) Frityrkoker.
NL7904859A (nl) Anti-transpiratiemiddelen en werkwijze ter bereiding daarvan.
NO148307C (no) Prosjektil for glattloepet vaapen og fremgangsmaate for fremstilling av samme.
NO853120L (no) Isfjell og fremgangsmaate for fremstilling av samme.
NO895194D0 (no) Fremgangsmaate for fremstilling av piperidinderivater.
DK336779A (da) 1,2,3,5-tetrahydroimidazothienopyrimidin-2-oner og fremgangsmmaade til fremstilling heraf
ES521031A0 (es) Procedimientos de obtencion de amidoaminoacidos y similares.
NO821159L (no) 2-piperazinopyrimidin og deres fremstilling.
NO162085C (no) Toeykondisjoneringsprodukt og fremgangsmaate til fremstilling av dette.
MX5719A (es) N-fenilsulfonil-n'-pirimidinil y -triazinil-ureas y procedimiento para su preparacion.
TR20938A (tr) Yeni suebstitueye tetrahidropiri-dimidion tuerevleri,bunlarin hazirlanisi icin usul ve bunlarin herbisidler olarak kullanilmalari
IT8020473A0 (it) Fenilmorfani intermedi eprocedimento di preparazione.
NO823974L (no) Serveringsfat-sett.
NO167788C (no) Fremgangsmaate for fremstilling av pastaer.
NO812115L (no) Fortilsetning, og fremgangsmaate for fremstilling derav.
NL193821B (nl) Farmaceutisch preparaat.
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
NO802048L (no) Tallysomycinderivat og fremgangsmaate til fremstilling av samme.
IT8019100A0 (it) 3-ariltio-4-idrossipirrolidine 1-sostituite e procedimento per laloro preparazione.
IT7922320A0 (it) 1,6-dimesil-3,4-dimetil-d-mannitolo e procedimento per la sua preparazione.
NO823424L (no) Fremgangsmaate til fremstilling og behandling av ferrokrom
TR20524A (tr) 3.(3,5dihalojenofenil)-oksazolidin 2,4-dionlar(tionlar)in suebstitueye spiro tuerevleri,bunlarin hazirlanisi icin usuller ve bunlarin funggsidler olarak kullanilmalari
ES517636A0 (es) Procedimiento de preparacion de haloalcohil-8-4h-(1)-benzo-piran-4-onas.